Sleep Medicine
Volume 1, Issue 2 , Pages 87-90 , 1 April 2000

Perspectives in narcolepsy and hypocretin (orexin) research

References 

  1. Nishino S, Ripley B, Overeem S, Lammers GJ, et al.  Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355(9197):39–40
  2. Lin L, Faraco J, Li R, Kadotani H, et al.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98(3):365–376
  3. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, et al.  Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98(4):437–451
  4. de Lecea L, Kilduff TS, Peyron C, Gao X, et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95(1):322–327
  5. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92(4):573–585
  6. Peyron C, Tighe DK, van den Pol AN, de Lecea L, et al.  Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18(23):9996–10015
  7. Nambu T, Sakurai T, Mizukami K, Hosoya Y, et al.  Distribution of orexin neurons in the adult rat brain. Brain Res. 1999;827(1–2):243–260
  8. van den Pol AN, Gao XB, Obrietan K, Kilduff TS, et al.  Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci. 1998;18(19):7962–7971
  9. Horvath TL, Peyron C, Diano S, Ivanov A, et al.  Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol. 1999;415(2):145–159
  10. Hagan JJ, Leslie RA, Patel S, Evans ML, et al.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 1999;96(19):10911–10916
  11. Trivedi P, Yu H, MacNeil DJ, Van der Ploeg LH, et al.  Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 1998;438(1–2):71–75
  12. Mignot E, Nishino S, Sharp LH, Arrigoni J, et al.  Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems. J Neurosci. 1993;13(3):1057–1064
  13. Karczmar AG, Longo VG, De Carolis AS. A pharmacological model of paradoxical sleep: the role of cholinergic and monoamine systems. Physiol Behav. 1970;5(2):175–182
  14. McCarley RW, Hobson JA. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science. 1975;189(4196):58–60
  15. Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol. 1997;52(1):27–78
  16. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998;50(2 Suppl 1):S16–S22
  17. Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron. 1999;24(4):941–951

PII: S1389-9457(00)00013-7

Sleep Medicine
Volume 1, Issue 2 , Pages 87-90 , 1 April 2000

Article Tools